BRPI1006145A2 - "composição e método para tratamento de diabetes". - Google Patents

"composição e método para tratamento de diabetes".

Info

Publication number: BRPI1006145A2
Authority: BR; Brazil
Prior art keywords: composition; treating diabetes; diabetes; treating
Prior art date: 2009-01-12

Application number

BRPI1006145A

Other languages

English (en)

Inventor

Jerzy Ryszard Szewczyk

Original Assignee

Biokier Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-01-12

Filing date

2010-01-11

Publication date

2017-05-30

2010-01-11 Application filed by Biokier Inc filed Critical Biokier Inc

2017-05-30 Publication of BRPI1006145A2 publication Critical patent/BRPI1006145A2/pt

2021-03-09 Publication of BRPI1006145B1 publication Critical patent/BRPI1006145B1/pt

2021-05-25 Publication of BRPI1006145B8 publication Critical patent/BRPI1006145B8/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Reproductive Health (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)

BRPI1006145A 2009-01-12 2010-01-11 composição e método para tratamento de diabetes BRPI1006145B8 (pt)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US14395109P	2009-01-12	2009-01-12
US61/143,951		2009-01-12
US29377310P	2010-01-11	2010-01-11
US61/293,773		2010-01-11
PCT/US2010/020629 WO2010081079A2 (en)	2009-01-12	2010-01-11	Composition and method for treatment of diabetes

Publications (3)

Publication Number	Publication Date
BRPI1006145A2 true BRPI1006145A2 (pt)	2017-05-30
BRPI1006145B1 BRPI1006145B1 (pt)	2021-03-09
BRPI1006145B8 BRPI1006145B8 (pt)	2021-05-25

Family

ID=42317190

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1006145A BRPI1006145B8 (pt)	2009-01-12	2010-01-11	composição e método para tratamento de diabetes

Country Status (23)

Country	Link
US (2)	US8470885B2 (pt)
EP (1)	EP2376077B1 (pt)
JP (1)	JP5702306B2 (pt)
KR (4)	KR20170034928A (pt)
CN (1)	CN102355896A (pt)
AU (1)	AU2010203413B2 (pt)
BR (1)	BRPI1006145B8 (pt)
CA (1)	CA2748827C (pt)
CL (1)	CL2011001692A1 (pt)
CY (1)	CY1119010T1 (pt)
DK (1)	DK2376077T3 (pt)
EA (1)	EA022631B1 (pt)
ES (1)	ES2628233T3 (pt)
HR (1)	HRP20170886T1 (pt)
HU (1)	HUE034551T2 (pt)
LT (1)	LT2376077T (pt)
MX (1)	MX2011007393A (pt)
PL (1)	PL2376077T3 (pt)
PT (1)	PT2376077T (pt)
RS (1)	RS56054B1 (pt)
SI (1)	SI2376077T1 (pt)
SM (1)	SMT201700278T1 (pt)
WO (1)	WO2010081079A2 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102316889B (zh)	2008-11-26	2014-11-26	萨蒂奥根制药公司	组合物及使用方法
US20220071895A1 (en) *	2009-01-12	2022-03-10	Biokier, Inc.	Composition and method for treatment of diabetes
US20150224081A1 (en) *	2009-01-12	2015-08-13	Biokier, Inc.	Composition and method for treatment of diabetes
WO2012161670A2 (en)	2010-04-07	2012-11-29	Incube Labs, Llc	Method for treating diabetes and other glucose regulation disorders using stem cells
CN103429739B (zh)	2010-05-12	2018-11-13	哥伦比亚大学纽约管理委员会	制备产生和分泌胰岛素的肠内分泌细胞的方法
KR20140030171A (ko) *	2011-05-02	2014-03-11	바이오키어 인코포레이티드	당뇨병 치료를 위한 조성물 및 치료법
KR20130055220A (ko)	2011-11-18	2013-05-28	삼성전자주식회사	동박적층판 및 이를 사용한 금속코어기판의 제조방법
CN108478551A (zh) *	2011-11-21	2018-09-04	埃默斯医疗股份有限公司	用于治疗糖尿病和相关病症的方法和组合物
US20150073057A1 (en) *	2013-09-06	2015-03-12	Biokier, Inc.	Composition and method for treatment of diabetes
CA2985344A1 (en)	2014-06-26	2015-12-30	The Trustees Of Columbia University In The City Of New York	Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells
EP4194001A1 (en) *	2015-04-22	2023-06-14	Cedars-Sinai Medical Center	Enterically delivered bitter oligopeptides for the treatment for type 2 diabetes and obesity
US11291693B2 (en)	2015-06-25	2022-04-05	Synlogic Operating Company, Inc.	Bacteria engineered to treat metabolic diseases
US9668991B1 (en)	2015-12-09	2017-06-06	International Business Machines Corporation	SCFA colonic composition
CN107684550B (zh) *	2016-08-03	2020-04-10	徐天宏	糖尿病治疗产品及其制备与应用
JOP20190146A1 (ar)	2016-12-19	2019-06-18	Axcella Health Inc	تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
US20210084956A1 (en)	2018-02-23	2021-03-25	Ambra Bioscience Llc	Compositions and methods for hunger control and weight management
WO2019246225A1 (en)	2018-06-20	2019-12-26	Axcella Health Inc.	Compositions and methods for the treatment of fat infiltration in muscle
KR20220046623A (ko)	2019-08-12	2022-04-14	메사추세츠 인스티튜트 오브 테크놀로지	치료제의 투여를 위한 물품 및 방법
US20230190686A1 (en) *	2021-12-17	2023-06-22	Biokier, Inc.	Composition and method for treatment of diabetes

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA885473B (en) *	1987-08-07	1989-03-29	Century Lab Inc	Free fatty acids for treatment of diabetes mellitus
IT1245890B (it) *	1991-04-12	1994-10-25	Alfa Wassermann Spa	Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
WO1999007342A1 (en)	1997-08-11	1999-02-18	Alza Corporation	Prolonged release active agent dosage form adapted for gastric retention
US6652882B1 (en)	1997-10-06	2003-11-25	Intellipharmaceutics Corp	Controlled release formulation containing bupropion
GB9722426D0 (en)	1997-10-23	1997-12-24	Univ London Pharmacy	Controlled release formulations
IL142650A (en)	1998-04-08	2007-06-03	Galmed Int Ltd	Use of bile acid conjugates or bile salts and fatty acids or fatty acids in the preparation of pharmaceuticals for lowering cholesterol, for the treatment of fatty liver and for the treatment of hyperglycemia and diabetes
DK1183014T3 (da)	1999-06-14	2004-02-09	Cosmo Spa	Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
EP1364957B1 (en)	2001-02-26	2008-12-31	Kissei Pharmaceutical Co., Ltd.	Glycopyranosyloxypyrazole derivatives and medicinal use thereof
US20030203004A1 (en) *	2002-04-24	2003-10-30	Kelm Gary Robert	Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight
US7135575B2 (en) *	2003-03-03	2006-11-14	Array Biopharma, Inc.	P38 inhibitors and methods of use thereof
DE60300502T2 (de)	2003-10-28	2006-02-23	Adorkem Technology S.P.A., Costa Volpino	Verfahren zur Herstellung von Citalopram
ITMI20040187A1 (it)	2004-02-06	2004-05-06	Cosmo Spa	Composizioni farmaceutiche o dietetiche a base di acidi grassi a catena corta e zuccheri complessi per le disfunzioni intestinali
ITMI20041295A1 (it)	2004-06-25	2004-09-25	Cosmo Spa	Composizioni farmaceutiche antimicrobiche orali
JP2006056881A (ja)	2004-07-21	2006-03-02	Takeda Chem Ind Ltd	縮合環化合物
JP2006063064A (ja)	2004-07-27	2006-03-09	Takeda Chem Ind Ltd	受容体作動剤
AU2006250354A1 (en)	2005-05-23	2006-11-30	Japan Tobacco Inc.	Pyrazole compound and therapeutic agent for diabetes comprising the same
DE102005046237A1 (de) *	2005-09-28	2007-04-05	Südzucker Aktiengesellschaft Mannheim/Ochsenfurt	Buttersäureester von Kohlenhydraten und Kohlenhydratpolyolen
ITMI20052000A1 (it) *	2005-10-21	2007-04-22	Promefarm S R L	Compressa gastroresitente a base di butirrato di sodio
CN101404987A (zh)	2006-01-20	2009-04-08	史密丝克莱恩比彻姆公司	磺酰胺衍生物在治疗代射和神经系统疾病中的用途
US20090035306A1 (en)	2006-11-29	2009-02-05	Kalypsys, Inc.	Quinazolinone modulators of tgr5
CA2673054C (en) *	2006-12-15	2016-05-10	Tima Foundation	Novel compositions and uses thereof
WO2010062861A2 (en)	2008-11-26	2010-06-03	Satiogen Pharmaceuticals, Inc.	Bile acid recycling inhibitors for treatment of obesity and diabetes
CN102316889B (zh)	2008-11-26	2014-11-26	萨蒂奥根制药公司	组合物及使用方法
BRPI1007518A2 (pt)	2009-02-10	2018-02-20	Amarin Pharma, Inc.	uso de acido etil ester eicopentanoico para tratamento de hipertrigliceridemia
AU2010260129B2 (en)	2009-06-15	2014-05-29	Amarin Pharmaceuticals Ireland Limited	Compositions and methods for lowering triglycerides without raising LDL-C levels
BR112012006692B8 (pt)	2009-09-23	2021-05-25	Amarin Corp Plc	composição farmacêutica compreendendo um derivado de hidróxi de atorvastatina e um óleo compreendendo etil eicosapentaenoato ou etil docosahexaenoato

2010
- 2010-01-11 EP EP10729620.4A patent/EP2376077B1/en active Active
- 2010-01-11 ES ES10729620.4T patent/ES2628233T3/es active Active
- 2010-01-11 RS RS20170584A patent/RS56054B1/sr unknown
- 2010-01-11 PT PT107296204T patent/PT2376077T/pt unknown
- 2010-01-11 EA EA201190068A patent/EA022631B1/ru unknown
- 2010-01-11 SM SM20170278T patent/SMT201700278T1/it unknown
- 2010-01-11 KR KR1020177007518A patent/KR20170034928A/ko not_active Ceased
- 2010-01-11 KR KR1020117015982A patent/KR20110120866A/ko not_active Ceased
- 2010-01-11 JP JP2011545487A patent/JP5702306B2/ja active Active
- 2010-01-11 AU AU2010203413A patent/AU2010203413B2/en not_active Ceased
- 2010-01-11 BR BRPI1006145A patent/BRPI1006145B8/pt not_active IP Right Cessation
- 2010-01-11 CA CA2748827A patent/CA2748827C/en active Active
- 2010-01-11 DK DK10729620.4T patent/DK2376077T3/en active
- 2010-01-11 HR HRP20170886TT patent/HRP20170886T1/hr unknown
- 2010-01-11 CN CN201080004432XA patent/CN102355896A/zh active Pending
- 2010-01-11 KR KR1020197015093A patent/KR20190062609A/ko not_active Ceased
- 2010-01-11 KR KR1020177034790A patent/KR20170138573A/ko not_active Ceased
- 2010-01-11 WO PCT/US2010/020629 patent/WO2010081079A2/en not_active Ceased
- 2010-01-11 MX MX2011007393A patent/MX2011007393A/es active IP Right Grant
- 2010-01-11 LT LTEP10729620.4T patent/LT2376077T/lt unknown
- 2010-01-11 PL PL10729620T patent/PL2376077T3/pl unknown
- 2010-01-11 HU HUE10729620A patent/HUE034551T2/en unknown
- 2010-01-11 US US13/143,766 patent/US8470885B2/en active Active
- 2010-01-11 SI SI201031473T patent/SI2376077T1/sl unknown
2011
- 2011-07-11 CL CL2011001692A patent/CL2011001692A1/es unknown
2012
- 2012-10-08 US US13/646,778 patent/US8680085B2/en active Active
2017
- 2017-06-12 CY CY20171100614T patent/CY1119010T1/el unknown

Also Published As

Publication number	Publication date
KR20190062609A (ko)	2019-06-05
JP5702306B2 (ja)	2015-04-15
EP2376077B1 (en)	2017-03-15
EA201190068A1 (ru)	2012-01-30
SI2376077T1 (sl)	2017-09-29
EA022631B1 (ru)	2016-02-29
CA2748827C (en)	2017-10-10
US8470885B2 (en)	2013-06-25
JP2012515163A (ja)	2012-07-05
WO2010081079A3 (en)	2010-11-25
CN102355896A (zh)	2012-02-15
WO2010081079A2 (en)	2010-07-15
DK2376077T3 (en)	2017-06-26
HRP20170886T1 (hr)	2017-09-08
AU2010203413A1 (en)	2011-07-14
BRPI1006145B8 (pt)	2021-05-25
AU2010203413B2 (en)	2015-05-14
EP2376077A2 (en)	2011-10-19
CL2011001692A1 (es)	2012-04-13
LT2376077T (lt)	2017-08-10
RS56054B1 (sr)	2017-09-29
KR20110120866A (ko)	2011-11-04
KR20170034928A (ko)	2017-03-29
PL2376077T3 (pl)	2017-10-31
ES2628233T3 (es)	2017-08-02
US8680085B2 (en)	2014-03-25
MX2011007393A (es)	2011-10-06
BRPI1006145B1 (pt)	2021-03-09
US20110275716A1 (en)	2011-11-10
EP2376077A4 (en)	2012-08-29
CA2748827A1 (en)	2010-07-15
US20130102581A1 (en)	2013-04-25
KR20170138573A (ko)	2017-12-15
SMT201700278T1 (it)	2017-07-18
HUE034551T2 (en)	2018-02-28
CY1119010T1 (el)	2018-01-10
PT2376077T (pt)	2017-06-23

Publication	Publication Date	Title
BRPI1006145A2 (pt)	2017-05-30	"composição e método para tratamento de diabetes".
BRPI1007477A2 (pt)	2016-02-16	método, e, composição de tratamento de poço
BRPI0922122A2 (pt)	2017-08-01	composições e métodos para tratamento de doença celíaca.
BRPI0919575A2 (pt)	2017-03-28	método, e, composição
BRPI0818732A2 (pt)	2014-10-07	Composições de análogo de prostaglandina e métodos para tratar condições relacionadas epiteliais.
BRPI0918170A2 (pt)	2015-12-01	método, e, composição endurecível
BRPI0809690A2 (pt)	2014-10-07	Composição de lubrificante, e, método
BRPI0823277A2 (pt)	2015-06-23	Composição, e , método
BRPI0809573A2 (pt)	2016-07-26	composição, e, método
BR112012000171A2 (pt)	2016-03-15	composição lubrificante, e, método
BRPI0911757A2 (pt)	2013-09-17	composiÇÕes e mÉtodos para tratar distérbios digestivos.
BRPI0814941A2 (pt)	2014-09-30	Composição de tratamentode semente, e, método de tratamento de semente.
BRPI0820139A2 (pt)	2014-09-30	Composição antiperspirante ativa, e, processo de obtenção de uma composição antiperspirante ativa
BRPI0815057A2 (pt)	2015-07-28	Composto, composição farmacêutica, e, método para tratar infecção.
BRPI0911077A2 (pt)	2015-12-29	método para tratamento de biomassa
BRPI1007929A2 (pt)	2015-09-01	"métodos e composições para o tratamento de neovascularização".
BRPI0814167A2 (pt)	2015-01-20	Composição, e, método
BR112013003529A2 (pt)	2016-06-28	"composição aerada, composição de tratamento capilar método para o tratamento capilar"
BRPI0909164A2 (pt)	2016-06-21	método e composições para o tratamento de câncer
BRPI1011012A2 (pt)	2018-06-12	composição de lubrificante, e, método
BRPI0822472A2 (pt)	2015-06-16	Método, camundongo, e, composição
BRPI0719707A2 (pt)	2014-02-18	Composição e método para dermatite causada por fraldas.
BR112012003151A2 (pt)	2016-04-19	composição de revestimento, e, método.
BRPI0823238A2 (pt)	2015-06-16	Composição, e, método
BRPI0914584A2 (pt)	2015-08-04	Método, e, composição herbicida.

Legal Events

Date	Code	Title	Description
2017-06-06	B15I	Others concerning applications: loss of priority
2017-08-29	B12F	Other appeals [chapter 12.6 patent gazette]
2018-10-23	B06T	Formal requirements before examination [chapter 6.20 patent gazette]
2019-10-01	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]	Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.
2020-08-11	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2020-09-08	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2020-12-29	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-03-09	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/03/2021, OBSERVADAS AS CONDICOES LEGAIS.
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/01/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2025-11-11	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 16A ANUIDADE.